-+ 0.00%
-+ 0.00%
-+ 0.00%

Entrada Therapeutics Unveils Pipeline Progress and Clinical Milestones for Duchenne and Myotonic Dystrophy Programs

路透·12/15/2025 17:45:39

登录查看新闻详情